CompletedPHASE2, PHASE3NCT00510692

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

Studying Familial adenomatous polyposis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
S.L.A. Pharma AG
Principal Investigator
Nicholas J West, MB BS FRCS
The Polyposis Registry, St. Mark's Hospital,
Intervention
Eicosapentanoic Acid (EPA)(drug)
Enrollment
58 enrolled
Eligibility
18 years · All sexes
Timeline
20062008

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00510692 on ClinicalTrials.gov

Other trials for Familial adenomatous polyposis

Additional recruiting or active studies for the same condition.

See all trials for Familial adenomatous polyposis

← Back to all trials